← Back to patent-cliff list
XNW-7201
Tier C — Watch / tradeXNW-7201
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PORCN
Indications (approved)：Colon cancer, Oesophageal cancer, Gastric cancer, Pancreatic cancer, 胃肠道癌症, Solid tumour
Regional status
US
-
EU
-
China
Phase II
2020-06-09
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of XNW-7201?
Approved indications include: Colon cancer, Oesophageal cancer, Gastric cancer, Pancreatic cancer, 胃肠道癌症, Solid tumour.
When does the XNW-7201 patent expire?
No public expiry year is available for XNW-7201 yet; this page updates once verified.
How do I get a quote for XNW-7201 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-07